Parallel Advisors’s ADMA Biologics ADMA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.1K | Buy |
552
+32
| +6% | +$583 | ﹤0.01% | 2453 |
|
|
2025
Q1 | $10.3K | Buy |
520
+66
| +15% | +$1.31K | ﹤0.01% | 2411 |
|
|
2024
Q4 | $7.79K | Buy |
454
+21
| +5% | +$360 | ﹤0.01% | 2470 |
|
|
2024
Q3 | $8.66K | Buy |
433
+65
| +18% | +$1.3K | ﹤0.01% | 2428 |
|
|
2024
Q2 | $4.11K | Buy |
368
+128
| +53% | +$1.43K | ﹤0.01% | 2577 |
|
|
2024
Q1 | $1.58K | Hold |
240
| – | – | ﹤0.01% | 2858 |
|
|
2023
Q4 | $1.09K | Sell |
240
-721
| -75% | -$3.26K | ﹤0.01% | 2917 |
|
|
2023
Q3 | $3.44K | Hold |
961
| – | – | ﹤0.01% | 2634 |
|
|
2023
Q2 | $3.55K | Hold |
961
| – | – | ﹤0.01% | 2555 |
|
|
2023
Q1 | $3.18K | Buy |
961
+120
| +14% | +$397 | ﹤0.01% | 2585 |
|
|
2022
Q4 | $3.26K | Hold |
841
| – | – | ﹤0.01% | 2495 |
|
|
2022
Q3 | $2K | Buy |
+841
| New | +$2K | ﹤0.01% | 2547 |
|
|
2022
Q2 | – | Sell |
-11,954
| Closed | -$22K | – | 2929 |
|
|
2022
Q1 | $22K | Buy |
+11,954
| New | +$22K | ﹤0.01% | 1661 |
|